Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.
Public ClinicalTrials.gov record NCT01193257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or Following Docetaxel-based Therapy.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic, castration-resistant prostate cancer (mCRPC) that has progressed following Docetaxel-based therapy
Study identification
- NCT ID
- NCT01193257
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,099 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2010 (Actual)
- Primary completion
- May 16, 2013 (Actual)
- Completion
- Feb 29, 2016 (Actual)
- Last update posted
- Dec 19, 2018
2010 – 2016
United States locations
- U.S. sites
- 37
- U.S. states
- 22
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anchorage | Alaska | 99508 | — |
| Not listed | Fort Smith | Arkansas | 72903 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Los Angeles | California | 90025 | — |
| Not listed | Riverside | California | 92501 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | Fort Myers | Florida | 33916 | — |
| Not listed | Port Saint Lucie | Florida | 34952 | — |
| Not listed | Indianapolis | Indiana | 46219 | — |
| Not listed | Jeffersonville | Indiana | 47130 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Westminster | Maryland | 21157 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Jefferson City | Missouri | 65109 | — |
| Not listed | Las Vegas | Nevada | 89169 | — |
| Not listed | Hackensack | New Jersey | 07601 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | East Syracuse | New York | 13057 | — |
| Not listed | Rochester | New York | 14623 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Cincinnati | Ohio | 45230 | — |
| Not listed | Tualatin | Oregon | 97062 | — |
| Not listed | Lancaster | Pennsylvania | 17604 | — |
| Not listed | Pittsburgh | Pennsylvania | 15212 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Amarillo | Texas | 79106 | — |
| Not listed | Bedford | Texas | 76022 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Odessa | Texas | 79761 | — |
| Not listed | Tyler | Texas | 75702 | — |
| Not listed | Webster | Texas | 77598 | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Newport News | Virginia | 23606 | — |
| Not listed | Kennewick | Washington | 99336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01193257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01193257 live on ClinicalTrials.gov.